Not yet.
Diagnosing obstructive coronary artery disease (CAD) without the use of invasive procedures or exposure to radiation and contrast agents remains a clinical challenge. In a multicenter, prospective trial, investigators used gene expression testing to analyze blood samples from nondiabetic patients scheduled to undergo coronary angiography. Risk for obstructive CAD (defined as atherosclerotic plaque causing ≥50% stenosis in one or more major coronary arteries) was scored according to an algorithm developed by the study sponsor.
The primary endpoint was the area under the receiver-operating characteristics (ROC) curve for the algorithm's prediction of obstructive CAD. The authors used the Diamond-Forrester risk score, based on age, sex, and che…
Reviewing Author
DisclosuresGrant/Research SupportNIH–National Heart, Lung, and Blood Institute
DisclosuresGrant/Research SupportNIH–National Heart, Lung, and Blood Institute